Related Experiment Video

Updated: Jun 19, 2026

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

VACCINE TREATMENT IN THE PREVENTION OF DYSENTERY IN INFANTS

W P Lucas1, H L Amoss

  • 1Out-Patient Department of the Infant's Hospital and from the Department of Preventive Medicine and Hygiene, Harvard Medical School.

The Journal of Experimental Medicine
|October 30, 2009
PubMed

Insights

This study found that a new vaccine was safe, causing only mild reactions in most patients. It may offer a way to prevent infant dysentery mortality.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • Infant dysentery, particularly during summer months, leads to significant mortality.
  • Existing treatments may not fully address the rapid onset of the disease.

Purpose of the Study:

  • To evaluate the safety and potential efficacy of a novel vaccine against dysentery.
  • To assess the vaccine's impact on both clinically apparent and subclinical cases of bacterial dysentery.

Main Methods:

  • Administration of a vaccine to a small cohort of patients.
  • Observation of patient reactions and clinical outcomes.
  • Bacteriological analysis to identify *B. dysenteriae* presence.

Main Results:

  • The vaccine demonstrated a favorable safety profile with minimal and short-lived adverse reactions.
  • No significant difference in outcomes was observed between patients with bacteriologically confirmed and culturally negative dysentery.
  • The vaccine's immediate passive immunity effect was noted, contrasting with the slower active immunity from bacterial vaccines.

Conclusions:

  • The investigated vaccine is safe for use in infants.
  • The vaccine shows potential as a preventive measure against high infant dysentery mortality.
  • Further research is warranted to confirm efficacy in larger populations.

More Related Videos

Epithelial Cell Infection Analyses with Shigella04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...